Health Condition 1: null- chronic otitis media mucosal type
Conditions
Interventions
Intervention1: platelet rich plasma: blood component, dose-2ml
frequency- 1 dose
duration- 6 months
Control Intervention1: Polyvinyl aldehyde: polyvinyl aldehyde
it is a absorable material will be pla
Sponsors
AIIMS Bhubaneswar
Eligibility
Inclusion criteria
Inclusion criteria: Cases of chronic suppurative otitis media (CSOM) of mucosal type with medium to large perforation with conductive hearing loss
Exclusion criteria
Exclusion criteria: Cases with squamous type of CSOM CSOM with small perforation history of past ear surgery/ revision cases sensorineural hearing loss uncontrolled Diabetes mellitus, Hypertension, other systemic illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the efficacy of platelet rich plasma on temporalis fascia graft myringoplasty with respect to Graft uptake Timepoint: each patient will be assessed at 1 week, 1 month, 3 month, 6 month duration post operatively. overall assessment will be done on 1-7-2019 | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the efficacy of platelet rich plasma on temporalis fascia graft myringoplasty with respect to Improvement of hearingTimepoint: 6 months postoperatively | — |
Countries
India
Contacts
Public ContactDr Pradipta Kumar Parida
All India Institute Of Medical Sciences
Outcome results
None listed